Summary
- The Himachal Pradesh High Court's recent judgment could pose significant challenges to the Centre's efforts in combating the distribution of counterfeit drugs.
- This ruling raises questions about the legal framework surrounding drug regulation and enforcement in India.
- Experts warn that the implications of this decision may hinder ongoing initiatives aimed at ensuring public health safety.
- The Centre must now navigate these legal complexities to effectively address the issue of bad drugs in the market.
Join the discussion — sign up to comment, upvote, and save articles.